BHCM
ACAD icon

Brevan Howard Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Brevan Howard Capital Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$204K Sell
9,181
-25,010
-73% -$598K ﹤0.01% 1886
2025
Q4 		$913K Sell
34,191
-801
-2% -$19.1K 0.02% 810
2025
Q3 		$747K Buy
+34,992
New +$828K 0.01% 1057
2025
Q1 		– Sell
-56,749
Closed -$1.04M – 1123
2024
Q4 		$1.04M Buy
56,749
+43,270
+321% +$698K 0.03% 422
2024
Q3 		$207K Sell
13,479
-19,857
-60% -$331K 0.01% 985
2024
Q2 		$542K Sell
33,336
-513
-2% -$8.28K 0.04% 580
2024
Q1 		$626K Buy
33,849
+16,039
+90% +$397K 0.06% 386
2023
Q4 		$558K Buy
+17,810
New +$425K 0.06% 432

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return